Kraws Jeffrey J 4
4 · Synthetic Biologics, Inc. · Filed Dec 21, 2017
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Award
Stock Options
2017-12-20+200,000→ 200,000 totalExercise: $0.52From: 2018-12-20Exp: 2024-12-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]These stock options vest in full on the one year anniversary of the grant date.